Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-004194
Filing Date
2025-06-11
Accepted
2025-06-11 17:46:07
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3923
  Complete submission text file 0001950047-25-004194.txt   5403
Mailing Address 11 GREAT VALLEY PARKWAY MALVERN PA 19355
Business Address 11 GREAT VALLEY PARKWAY MALVERN PA 19355 484-328-4701
Ocugen, Inc. (Subject) CIK: 0001372299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-36751 | Film No.: 251041065
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 114 MILTON AVENUE CHAPEL HILL NC 27514
Business Address
Fernandes Prabhavathi (Reporting) CIK: 0001540883 (see all company filings)

Type: 144